181 – 190 of 295
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity.
(
- Contribution to journal › Article
-
Mark
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).
(
- Contribution to journal › Article
-
Mark
Reaching beyond HIV/HCV: nelfinavir as a potential starting point for broad-spectrum protease inhibitors against dengue and chikungunya virus
(
- Contribution to journal › Article
-
Mark
Chapter 9: Evidence based pharmacy for developing countries
(
- Contribution to journal › Article
-
Mark
Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
(
- Contribution to journal › Scientific review
-
Mark
Molecularly Imprinted Polymer Nanocarriers for Sustained Release of Erythromycin.
(
- Contribution to journal › Article
-
Mark
Chapter 12: Evidence-based skills and practices for the future of pharmacy
(
- Contribution to journal › Article
-
Mark
Chapter 8: Generating knowledge
(
- Contribution to journal › Article
-
Mark
Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.
(
- Contribution to journal › Article
-
Mark
Virtual screening for identifying a putative inhibitor of rmlc, a major target protein in tuberculosis disease
(
- Contribution to journal › Article